Bajaj HealthCare Limited (BOM:539872)
India · Delayed Price · Currency is INR 324.55
-1.30 (-0.40%)
At close: Oct 22, 2026
Bajaj HealthCare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 6,558 | 6,110 | 5,426 | 4,734 | 6,458 | 6,799 |
| 6,558 | 6,110 | 5,426 | 4,734 | 6,458 | 6,799 | |
Revenue Growth | 14.25% | 12.61% | 14.61% | -26.69% | -5.01% | 3.49% |
Cost of Revenue | 3,463 | 3,230 | 2,947 | 2,574 | 3,849 | 4,995 |
Gross Profit | 3,095 | 2,880 | 2,479 | 2,160 | 2,609 | 1,804 |
Selling, General & Admin | 696.89 | 639.71 | 579.02 | 446.19 | 432.72 | 412.63 |
Other Operating Expenses | 1,263 | 1,190 | 1,076 | 949.25 | 1,060 | 172.21 |
Operating Expenses | 2,255 | 2,105 | 1,934 | 1,672 | 1,665 | 761.21 |
Operating Income | 840.48 | 774.92 | 544.55 | 488.35 | 943.37 | 1,043 |
Interest Expense | -226.52 | -213.7 | -251.22 | -290.53 | -163.99 | -110.01 |
Interest & Investment Income | 3.12 | 3.12 | 5.1 | 3.29 | 4.28 | 1.72 |
Currency Exchange Gain (Loss) | 65.14 | 65.14 | 101.38 | 18.77 | - | -19.39 |
Other Non Operating Income (Expenses) | -17.59 | -9.33 | 30.58 | -6.94 | -10.09 | -17.81 |
EBT Excluding Unusual Items | 664.63 | 620.16 | 430.39 | 212.93 | 773.57 | 897.66 |
Gain (Loss) on Sale of Assets | 1.54 | 1.54 | 3.35 | 0.36 | 0.04 | - |
Asset Writedown | - | - | - | -443.28 | - | - |
Other Unusual Items | -332.47 | -332.47 | - | - | - | -1 |
Pretax Income | 333.7 | 289.23 | 460.08 | -166.76 | 781.82 | 896.85 |
Income Tax Expense | 84.09 | 76.13 | 30.79 | -23.49 | 146.5 | 182.99 |
Earnings From Continuing Operations | 249.61 | 213.1 | 429.29 | -143.27 | 635.33 | 713.86 |
Earnings From Discontinued Operations | -43.46 | -55.44 | -34.33 | -694.67 | -205.08 | - |
Net Income | 206.15 | 157.66 | 394.96 | -837.93 | 430.24 | 713.86 |
Net Income to Common | 206.15 | 157.66 | 394.96 | -837.93 | 430.24 | 713.86 |
Net Income Growth | -55.03% | -60.08% | - | - | -39.73% | -14.11% |
Shares Outstanding (Basic) | 33 | 32 | 30 | 28 | 28 | 28 |
Shares Outstanding (Diluted) | 33 | 32 | 30 | 28 | 28 | 28 |
Shares Change | 1.28% | 5.26% | 9.09% | - | - | - |
EPS (Basic) | 6.30 | 4.98 | 13.29 | -30.36 | 15.59 | 25.87 |
EPS (Diluted) | 6.30 | 4.97 | 13.12 | -30.36 | 15.59 | 25.87 |
EPS Growth | -55.63% | -62.11% | - | - | -39.73% | -14.09% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -697.45 | 147.32 | 100.82 | 620.08 | -1,158 | -786.19 |
Free Cash Flow Per Share | -21.32 | 4.65 | 3.35 | 22.47 | -41.95 | -28.49 |
Dividend Per Share | - | 1.500 | 1.000 | 1.000 | 1.000 | 1.500 |
Dividend Growth | - | 50.00% | 0% | 0% | -33.33% | 71.43% |
Gross Margin | 47.20% | 47.14% | 45.68% | 45.63% | 40.39% | 26.54% |
Operating Margin | 12.82% | 12.68% | 10.04% | 10.32% | 14.61% | 15.34% |
Profit Margin | 3.14% | 2.58% | 7.28% | -17.70% | 6.66% | 10.50% |
Free Cash Flow Margin | -10.63% | 2.41% | 1.86% | 13.10% | -17.93% | -11.56% |
EBITDA | 1,100 | 1,015 | 814.6 | 800.76 | 1,216 | 1,220 |
EBITDA Margin | 16.78% | 16.61% | 15.01% | 16.91% | 18.82% | 17.94% |
D&A For EBITDA | 259.62 | 240.17 | 270.05 | 312.41 | 272.35 | 176.37 |
EBIT | 840.48 | 774.92 | 544.55 | 488.35 | 943.37 | 1,043 |
EBIT Margin | 12.82% | 12.68% | 10.04% | 10.32% | 14.61% | 15.34% |
Effective Tax Rate | 25.20% | 26.32% | 6.69% | - | 18.74% | 20.40% |
Revenue as Reported | 6,621 | 6,182 | 5,620 | 4,821 | 6,474 | 6,813 |
Advertising Expenses | - | 12.18 | 8.44 | 7.66 | 6.58 | 0.94 |